The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Zanidatamab is the first agent approved specifically for advanced, HER2-positive second-line biliary tract cancer.

“I need to make sure the primary antibodies are from two different species,” he says. If they’re from the same species, the secondary antibodies can’t distinguish them. Many of the ...

The membrane is then incubated with an antibody called the primary antibody, which specifically binds to the protein of interest. Following incubation, any unbound primary antibody is washed away ...

Researchers identified a unique antibody signature against the Epstein-Barr virus protein EBNA1 that correlates with ...

Anti-IgG1, IgG2 and IgG3 as secondary antibody. # 17 additional healthy controls tested negative. IIF: Immunofluorescence; PBC: Primary biliary cirrhosis.